Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Irritable Bowel Syndrome and FAAH[original query] |
---|
Pharmacogenetic trial of a cannabinoid agonist shows reduced fasting colonic motility in patients with nonconstipated irritable bowel syndrome. Gastroenterology 2011 Nov 141 (5): 1638-47.e1-7. Wong Banny S, Camilleri Michael, Busciglio Irene, Carlson Paula, Szarka Lawrence A, Burton Duane, Zinsmeister Alan |
Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 2012 Jan . Wong BS, Camilleri M, Eckert D, Carlson P, Ryks M, Burton D, Zinsmeister AR |
Association of cannabinoid type 1 receptor and fatty acid amide hydrolase genetic polymorphisms in Chinese patients with irritable bowel syndrome. Journal of gastroenterology and hepatology 2014 Jun 29 (6): 1186-91. Jiang Yingjie, Nie Yuqiang, Li Yuyuan, Zhang Lo |
- Page last reviewed:Feb 1, 2024
- Content source: